GenMark Diagnostics, Inc. GNMK Cash Flow

Genmark diagnostics, inc. (GNMK)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities:
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-42,278	-47,350	-48,626	-47,944	-51,157	-50,500	0	0	0	-	-	-	-	-50,601	-46,705	-46,042	-45,286	-42,197	-42,027	-40,291	-39,349	-38,263	-40,283	-41,442	-38,251	-33,643	-27,704	-23,140	-20,720	-22,103	-22,846	-22,905	-22,886	-23,970	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
7,255	7,268	7,200	7,197	7,160	7,088	6,787	6,370	5,840	5,317	4,988	4,579	4,233	3,916	3,644	3,564	3,508	3,405	3,286	3,121	2,879	2,656	2,488	2,661	2,606	2,530	2,192	1,658	1,432	1,198	1,296	1,280	1,301	1,326	0	0	0
Net amortization (accretion) of premiums/discounts on investments
100	133	166	162	121	142	153	87	62	39	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred debt issuance costs
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net accretion of premiums/discounts on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	228	285	-420	-268	-125	0	444	331	198	0	0	0	0	-	-	-	-	-	-	-	-
Amortization of deferred debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of investment in preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
15,122	12,046	11,642	11,609	11,517	11,697	12,679	12,367	12,086	12,170	10,834	10,298	9,642	9,236	9,436	9,712	10,058	9,995	8,665	7,670	6,746	5,796	5,674	5,185	4,585	3,893	3,540	2,976	2,543	2,352	1,742	1,678	1,903	1,872	0	0	0
Provision for bad debt
367	338	0	0	0	-	-	-	-	14	51	22	-7	13	38	48	54	25	0	0	0	-	-	-	-	2,721	2,741	303	33	-24	-116	-90	20	0	0	0	0
Non-cash inventory adjustments
2,431	2,631	2,018	1,514	1,611	1,426	1,473	1,567	1,455	1,323	925	607	376	134	-1,041	-1,045	-921	-594	500	536	633	450	1,621	1,690	1,595	1,779	-370	804	557	-482	652	-346	-118	517	0	0	0
Other non-cash adjustments
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
16,918	5,584	682	-341	1,089	878	2,030	-3,741	-2,569	1,555	2,697	5,451	5,193	2,250	-293	1,908	1,043	1,983	2,738	1,430	1,868	2,030	354	114	905	2,390	3,944	3,443	3,342	2,068	312	556	311	420	0	0	0
Inventories
5,483	6,534	4,038	4,154	2,019	2,414	9,546	12,722	14,156	10,512	7,215	1,193	833	3,450	3,314	734	419	1,286	-542	1,083	764	229	888	-1,047	-387	1,313	-1,066	2,011	1,408	-880	696	205	1,011	1,742	0	0	0
Prepaid expenses and other assets
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-180	36	-827	209	507	184	547	81	-104	119	287	525	213	-68	-197	-281	-200	-1,846	0	0	0
Accounts payable
986	1,501	2,364	-679	-1,071	-1,389	617	3,838	4,017	2,557	1,721	-318	667	4,105	517	1,744	635	-757	45	-626	-241	85	455	1,152	765	1,343	391	49	969	728	775	-696	-402	378	0	0	0
Accrued compensation
1,040	-885	-400	-578	-424	1,059	1,242	54	-111	-263	-11	-117	39	2,172	698	892	1,450	-458	615	191	868	1,797	2,679	2,481	1,817	951	969	1,379	1,143	1,811	1,828	1,164	943	979	0	0	0
Other current and non-current liabilities
1,483	249	69	76	-94	-289	-736	-1,391	-871	-893	142	661	787	1,088	683	697	335	355	299	-317	-458	-537	-814	-305	-665	-544	13	1,061	2,155	1,397	0	0	0	-	-	-	-
Other current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Net cash used in operating activities
-34,350	-34,926	-29,183	-31,691	-34,641	-32,512	-41,717	-41,692	-43,909	-53,422	-51,083	-48,309	-45,159	-35,637	-33,394	-31,552	-29,693	-31,915	-31,020	-31,911	-31,453	-29,572	-28,528	-23,987	-24,076	-23,796	-21,260	-20,826	-16,851	-16,243	-17,688	-19,966	-21,620	-19,214	0	0	0
Investing activities:
Change in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-585	0	0	0	-	-	-	-	-	-	-	-
Payments for intellectual property licenses
-	-	-	-	-	-	-	-	-	-	-	-	-	1,500	800	800	800	550	550	900	900	350	344	537	537	882	909	933	933	1,327	0	0	0	-	-	-	-
Purchases of property and equipment
2,711	2,092	2,708	2,118	2,443	2,575	2,059	3,204	3,392	4,815	5,711	7,131	7,922	7,000	5,993	3,917	4,311	3,756	4,895	5,343	4,988	5,726	4,696	4,728	4,416	4,270	3,830	4,115	4,462	3,476	3,123	2,296	1,208	1,376	0	0	0
Purchases of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,646	14,797	14,651	29,812	28,054	51,403	84,184	75,381	76,190	0	0	0	-	-	-	-	-	-	-	-
Purchases of marketable securities
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of marketable securities
-	-	-	-	-	-	-	-	-	13,896	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of marketable securities
27,155	32,055	36,680	34,500	56,100	66,300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-
Net cash used in investing activities
-10,290	-2,172	6,244	6,786	19,765	33,947	40,192	-11,819	-27,981	-24,908	-31,827	-18,072	-9,649	-24,123	-21,778	17,752	18,740	19,321	28,131	25,779	29,671	29,417	-9,553	-49,474	-61,056	-72,564	-49,694	-23,847	-19,337	-2,146	-4,029	-3,404	-2,681	-7,110	0	0	0
Financing activities:
Proceeds from issuance of common stock, net of offering costs
16,181	14,021	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal repayment of borrowings
0	35,093	35,094	35,187	35,186	92	1,793	6,929	7,864	7,848	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings
20,000	70,000	57,098	57,098	57,098	7,098	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal repayment of borrowings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22	-	20	20	19	56	111	251	521	766	1,082	2,024	2,004	1,984	0	0	0	-	-	-	-
Proceeds from borrowings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Payments associated with debt issuance
150	3,638	3,588	3,588	3,588	20	20	20	187	187	247	247	100	90	30	30	28	718	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from borrowings
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	0	0	0
Proceeds from stock option exercises
130	457	432	432	435	22	96	139	216	287	418	530	455	712	510	447	1,112	989	1,316	1,245	728	531	233	298	316	396	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by financing activities
35,587	45,173	22,211	19,745	19,820	8,069	-750	-6,141	88,963	89,050	90,822	125,288	40,091	40,359	40,259	11,294	1,946	11,133	11,444	11,373	10,821	1,287	465	81,457	80,998	80,833	80,857	-710	44,404	44,319	44,040	44,019	30,995	33,262	0	0	0
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash
-	-	-	-	-	28	119	116	27	75	-44	-41	-18	-25	-6	-8	7	-9	-1	2	-9	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents
-	-	-	-	-	9,532	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash, cash equivalents, and restricted cash
0	-	-	-	0	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,919	-2,514	-9,000	-1,470	8,554	5,243	9,030	1,132	-37,616	7,996	-4,134	-15,527	9,903	-45,383	8,216	25,930	22,370	20,702	6,747	6,991	0	0	0
Non-cash investing and financing activities:
Transfer of systems to property and equipment from inventory
2,516	2,846	704	1,555	1,471	1,689	10,800	7,375	5,039	4,885	-3,409	-1,313	640	263	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment purchased with capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109	0	0	0	-	-	-	-
Transfer of systems from property and equipment into inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	265	270	250	256	300	462	575	575	530	339	230	223	0	0	0	-	-	-	-
Property and equipment costs incurred but not paid included in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76	0	0	0
Property and equipment included in accounts payable
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-
Supplemental cash flow information:
Cash paid for income taxes, net
-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	6	-	6	13	33	24	40	41	29	21	0	0	0	-	-	-	-	-	-	-	-
Cash received for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash received for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	1,293	1,130	726	663	683	572	609	333	92	20	20	9	13	19	0	0	0	-	-	-	-	-	-	-	-
Cash paid for income taxes, net
130	155	117	156	176	165	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
4,726	3,946	3,401	2,862	2,281	2,028	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intellectual property acquisitions included in other current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	450	0	0	0	-	-	-	-	-	-	-	-